Identification of STRBP as a Novel JAK2 Fusion Partner Gene in a Young Adult With Philadelphia Chromosome-Like B-Lymphoblastic Leukemia

被引:7
|
作者
Zhang, Xin-Yue [1 ,2 ]
Dai, Hai-Ping [1 ,2 ]
Li, Zheng [1 ,2 ]
Yin, Jia [1 ,2 ]
Lang, Xing-Ping [3 ]
Yang, Chun-Xiao [3 ]
Xiao, Sheng [4 ]
Zhu, Ming-Qing [1 ,2 ]
Liu, Dan-Dan [1 ,2 ]
Liu, Hong [1 ,2 ]
Shen, Hong-Jie [1 ,2 ]
Wu, De-Pei [1 ,2 ]
Tang, Xiao-Wen [1 ,2 ]
机构
[1] Soochow Univ, Natl Clin Res Ctr Hematol Dis, Jiangsu Inst Hematol, Affiliated Hosp 1, Suzhou, Peoples R China
[2] Soochow Univ, Inst Blood & Marrow Transplantat, Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China
[3] Sano Suzhou Precis Med Co Ltd, Suzhou, Peoples R China
[4] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
来源
FRONTIERS IN ONCOLOGY | 2021年 / 10卷
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
fusion gene; STRBP-JAK2; Ph-like; chimeric antigen receptor; B-lymphoblastic leukemia; BINDING PROTEIN; KINASE; STRATEGIES;
D O I
10.3389/fonc.2020.611467
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Philadelphia chromosome-like B-lymphoblastic leukemia (Ph-like ALL) describes a group of genetically heterogeneous, Ph-negative entities with high relapse rates and poor prognoses. A Janus-kinase-2 (JAK2) rearrangement has been reported in approximately 7% of Ph-like ALL patients whose therapeutic responses to JAK inhibitors have been studied in clinical trials. Here, we report a novel STRBP-JAK2 fusion gene in a 21-year-old woman with Ph-like ALL. Although a normal karyotype was observed, a hitherto unreported JAK2 rearrangement was detected cytogenetically. STRBP-JAK2 fusion was identified by RNA sequencing and validated by Sanger sequencing. The Ph-like ALL proved refractory to traditional induction chemotherapy combined with ruxolitinib. The patient consented to infusion of autologous chimeric antigen receptor (CAR) T cells against both CD19 and CD22, which induced morphologic remission. Haplo-identical stem cell transplantation was then performed; however, she suffered relapse at just one month after transplantation. The patient subsequently received donor lymphocyte infusion after which she achieved and maintained a minimal residual disease negative remission. However, she succumbed to grade IV graft-versus-host disease 7 months post-transplant. In conclusion, this report describes a novel STRBP-JAK2 gene fusion in a Ph-like ALL patient with a very aggressive disease course, which proved resistant to chemotherapy combined with ruxolitinib but sensitive to immunotherapy. Our study suggests that CAR T-cell therapy may be a viable option for this type of leukemia.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Gene Landscape Identified in Philadelphia Chromosome Negative (Ph-) Adult B-lymphoblastic Leukemia and a Debating Role of CRLF2 Rearrangements in Clinical Outcome - a Single Institutional Experience
    Sharma, Rohit
    Seongseok, Yun
    Gajzer, David
    Zhang, Ling
    MODERN PATHOLOGY, 2019, 32
  • [32] Gene Landscape Identified in Philadelphia Chromosome Negative (Ph-) Adult B-lymphoblastic Leukemia and a Debating Role of CRLF2 Rearrangements in Clinical Outcome - a Single Institutional Experience
    Sharma, Rohit
    Seongseok, Yun
    Gajzer, David
    Zhang, Ling
    LABORATORY INVESTIGATION, 2019, 99
  • [33] A Novel Homozygous Nucleotide Deletion in the JAK2 Gene in a Pediatric Patient with B-cell Precursor Acute Lymphoblastic Leukemia
    Akin, Dilara Fatma
    Akkaya, Emel
    Kurekci, A. Emin
    Arslan, Cigdem
    Ezer, Ustun
    Akar, Nejat
    TURKISH JOURNAL OF HEMATOLOGY, 2012, 29 (02) : 185 - 187
  • [34] Identification of PML as novel PAX5 fusion partner gene in childhood acute lymphoblastic leukemia
    Nebral, K.
    Siebert, R.
    König, M.
    Haas, O. A.
    Strehl, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 1 - 1
  • [35] The diagnostic challenges and clinical course of a myeloid/lymphoid neoplasm with eosinophilia and ZBTB20-JAK2 gene fusion presenting as B-lymphoblastic leukemia
    Lee, Winston Y.
    Pfau, Ruthann B.
    Choi, Sarah M.
    Yang, Jiong
    Xiao, Hong
    Putnam, Eileen M.
    Ryan, Russell J. H.
    Bixby, Dale L.
    Shao, Lina
    COLD SPRING HARBOR MOLECULAR CASE STUDIES, 2020, 6 (02):
  • [36] CRLF2 and JAK2 in B-Progenitor Acute Lymphoblastic Leukemia: A Novel Association in Oncogenesis
    Roll, J. Devon
    Reuther, Gary W.
    CANCER RESEARCH, 2010, 70 (19) : 7347 - 7352
  • [37] Novel Recurrent Germline JAK2 G571S Variant in Childhood Acute B-Lymphoblastic Leukemia: A Double Hit One Pathway Scenario
    Auer, Franziska
    Lin, Minhui
    Nebral, Karin
    Gertzen, Christoph G. W.
    Haas, Oskar A.
    Kuhlen, Michaela
    Gohlke, Holger
    Izraeli, Shai
    Trka, Jan
    Hu, Jianda
    Borkhardt, Arndt
    Hauer, Julia
    BLOOD, 2018, 132
  • [38] Frequency of actionable gene fusions in patients with Philadelphia chromosome-like (Ph-like) B-acute lymphoblastic leukemia (ALL): A retrospective study from the Children's Oncology Group (COG)
    Reshmi, Shalini C.
    Harvey, Richard C.
    Smith, Amy
    Chen, I-Ming
    Valentine, Marc
    Liu, Yu
    Li, Yongjin
    Zhang, Jinghui
    Roberts, Kathryn G.
    Shao, Ying
    Easton, John
    Payne-Turner, Debbie
    Devidas, Meenakshi
    Heerema, Nyla
    Carroll, Andrew J.
    Raetz, Elizabeth A.
    Borowitz, Michael J.
    Wood, Brent L.
    Angiolillo, Anne L.
    Burke, Michael M.
    Salzer, Wanda L.
    Zweidler-McKay, Patrick A.
    Rabin, Karen R.
    Carroll, William L.
    Loh, Mignon L.
    Hunger, Stephen P.
    Mullighan, Charles G.
    Willman, Cheryl L.
    Gastier-Foster, Julie M.
    CANCER RESEARCH, 2015, 75
  • [39] Identification of a novel MEF2C::SS18L1 fusion in childhood acute B-lymphoblastic leukemia
    Chen, Chuqin
    Wang, Jiali
    Kang, Meiyun
    Wu, Peng
    Zhu, Liwen
    Fang, Yongjun
    Xue, Yao
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (06)
  • [40] Identification of a novel GOLGA4-JAK2 fusion gene in B-cell acute lymphoblastic leukaemia
    Downes, Charlotte E. J.
    Rehn, Jacqueline
    Heatley, Susan L.
    Yeung, David
    McClure, Barbara J.
    White, Deborah L.
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (03) : 700 - 705